[go: up one dir, main page]

AU6550394A - Novel pyrimidine nucleosides - Google Patents

Novel pyrimidine nucleosides

Info

Publication number
AU6550394A
AU6550394A AU65503/94A AU6550394A AU6550394A AU 6550394 A AU6550394 A AU 6550394A AU 65503/94 A AU65503/94 A AU 65503/94A AU 6550394 A AU6550394 A AU 6550394A AU 6550394 A AU6550394 A AU 6550394A
Authority
AU
Australia
Prior art keywords
pyrimidine nucleosides
novel pyrimidine
novel
nucleosides
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65503/94A
Inventor
Oscar Acevedo
Phillip Dan Cook
Martin G Dunkel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU6550394A publication Critical patent/AU6550394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65503/94A 1994-03-11 1994-03-11 Novel pyrimidine nucleosides Abandoned AU6550394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/002652 WO1995024185A1 (en) 1994-03-11 1994-03-11 Novel pyrimidine nucleosides

Publications (1)

Publication Number Publication Date
AU6550394A true AU6550394A (en) 1995-09-25

Family

ID=22242341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65503/94A Abandoned AU6550394A (en) 1994-03-11 1994-03-11 Novel pyrimidine nucleosides

Country Status (2)

Country Link
AU (1) AU6550394A (en)
WO (1) WO1995024185A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0767657A4 (en) * 1994-06-22 1999-01-20 Nexstar Pharmaceuticals Inc NEW METHOD FOR THE PRODUCTION OF KNOWN AND NEW 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILE SUBSTITUTION
CA2277159A1 (en) 1997-01-08 1998-07-16 Wolfgang Pieken Bioconjugation of macromolecules
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
ATE277065T1 (en) 1999-01-05 2004-10-15 Bio Merieux FUNCTIONALIZED COMPOUND, OPTIONALLY LABELED POLYNUCLEOTIDES AND METHOD FOR DETECTING A TARGET NUCLEIC ACID
AU2003210629A1 (en) 2002-01-23 2003-09-02 Proligo, Llc Methods for the integrated synthesis and purification of oligonucleotides
AU2003258612A1 (en) * 2002-08-14 2004-03-03 4Sc Ag Pyrimidones as antiviral agents
EP1389461A1 (en) * 2002-08-14 2004-02-18 Axxima Pharmaceuticals Aktiengesellschaft Pyrimidones with antiviral properties
WO2004058794A1 (en) 2002-12-31 2004-07-15 Proligo Llc Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
PL2604620T5 (en) 2003-05-30 2024-10-14 Gilead Pharmasset Llc Modified fluorinated nucleoside analogues
CN101023094B (en) 2004-07-21 2011-05-18 法莫赛特股份有限公司 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
NZ554442A (en) 2004-09-14 2011-05-27 Pharmasset Inc Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
EA201100851A1 (en) 2008-12-23 2012-04-30 Фармассет, Инк. NUCLEOSIDE ANALOGUES
EA019341B1 (en) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Nucleoside phosphoramidates
US8716263B2 (en) 2008-12-23 2014-05-06 Gilead Pharmasset Llc Synthesis of purine nucleosides
TWI576352B (en) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 Nucleoside phosphoramidates
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
MX2012011171A (en) 2010-03-31 2013-02-01 Gilead Pharmasset Llc Nucleoside phosphoramidates.
JP6069215B2 (en) 2010-11-30 2017-02-01 ギリアド ファーマセット エルエルシー Compound
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
EP3038601B1 (en) 2013-08-27 2020-04-08 Gilead Pharmasset LLC Combination formulation of two antiviral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755295A (en) * 1969-10-24 1973-08-28 Syntex Corp 1-(2-amino-2-deoxy-{62 -d-ribofuranosyl) pyrimidines and derivatives thereof
US3975374A (en) * 1970-12-21 1976-08-17 The Upjohn Company Process for preparing 2-thiouracil nucleosides
US5212295A (en) * 1990-01-11 1993-05-18 Isis Pharmaceuticals Monomers for preparation of oligonucleotides having chiral phosphorus linkages

Also Published As

Publication number Publication date
WO1995024185A1 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
IL131521A0 (en) Pyrimidine derivatives
AU6550394A (en) Novel pyrimidine nucleosides
AU3388893A (en) Pyrimidine derivatives
AU1416195A (en) Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines
AU1715695A (en) Pyrimidine fungicides
AU8033891A (en) Pyrimidine derivatives
AU3486195A (en) Pyrimidinone derivatives
AU6656696A (en) Substituted aminouracils
GB9506309D0 (en) Pyrimidine compounds
AU638840B2 (en) Pyrimidine derivative
AU3347295A (en) Substituted pyrimidine(thi)ones
AU7325996A (en) Pyrimidine derivatives
AU3467197A (en) Tetracyclical derivatives from pyrimidine
AU2546195A (en) Adenosine derivatives
AU6786896A (en) Pyrimidine nucleosides
AU6518396A (en) Pyrimidine nucleoside derivative
AU7938994A (en) Pyrimidine derivatives
AU6930196A (en) Uracil derivative
ZA987267B (en) Nucleosides
AU7646791A (en) Pyrimidine derivatives
AU696216C (en) Pyrimidine derivatives
AU6518296A (en) Pyrimidine nucleoside derivatives
GB9514267D0 (en) Pyrimidine nucleosides
GB9515978D0 (en) Pyrimidine nucleosides
GB2316077B (en) Pyrimidine Compounds